Clinical Trials Directory

Trials / Conditions / Regional Transitional Cell Cancer of the Renal Pelvis and Ureter

Regional Transitional Cell Cancer of the Renal Pelvis and Ureter

8 registered clinical trials studyying Regional Transitional Cell Cancer of the Renal Pelvis and Ureter.

StatusTrialSponsorPhase
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
WithdrawnGemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and
NCT01639521
University of Southern CaliforniaPhase 2
TerminatedVeliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Ur
NCT01282333
National Cancer Institute (NCI)Phase 1
CompletedGemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Functi
NCT00478361
M.D. Anderson Cancer CenterPhase 2
TerminatedVorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium
NCT00363883
National Cancer Institute (NCI)Phase 2
TerminatedSorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
NCT00112905
National Cancer Institute (NCI)Phase 2
CompletedSorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract
NCT00112671
National Cancer Institute (NCI)Phase 2
CompletedIxabepilone in Treating Patients With Advanced Urinary Tract Cancer
NCT00021099
National Cancer Institute (NCI)Phase 2